PART II: OLIGOMERIC Aβ25-35 CHAPTER 5: CELL CULTURE PART II: OLIGOMERIC AΒ SPRC PRE-TREATMENT CONFERRED PROTECTION ON GLIOMA CELLS INCUBATED WITH Aβ25-35 OLIGOMERS 5.1 Results Effects of aggregated Aβ25-35 on cell viability Cell viability (%control) 5.1.1 110% 100% 90% 80% ** ** 70% 60% 50% 0.01 0.1 Aβ25-35 (µM) Figure 19: Effects of aggregated Aβ25-35 on C6 glioma cell viability, expressed as percentage of cell viability compared to the untreated control ± S.E.M Aggregated Aβ25-35 resulted in a dosedependent decrease in cell viability µM and µM Aβ caused significant decrease in cell viability to about 65% of the normal control N=6, *: p